The future of biologic agents in the treatment of Sjögren's syndrome - Wikidata - wikimedia - TriplyDB

The future of biologic agents in the treatment of Sjögren's syndrome

The future of biologic agents in the treatment of Sjögren's syndrome

http://www.wikidata.org/entity/Q24681044

about

Preclinical validation of salivary biomarkers for primary Sjögren's syndrome Systems biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.Sphingosine-1-phosphate signaling in human submandibular cells.Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome.Health-related quality of life, employment and disability in patients with Sjogren's syndrome.Usefulness of MR imaging of the parotid glands in patients with secondary Sjögren's syndrome associated with rheumatoid arthritis.

P2860

Q34370333-BDA92EEE-EA4F-449F-A6E4-A270F4978101 Q37283425-832B72C3-7E6D-4F79-8590-5EFE5FABFA36 Q37912214-28D78A1D-E9C7-40B0-A069-F6AFC1F35FA3 Q38004932-7A99D576-2B89-4189-A756-2758EE0B35AB Q42962009-AAB823FF-815D-4090-BAEA-7253DA0EE7CF Q44868261-EF8FF1FF-2CE6-45CB-9DEA-B065570B32DB Q49160025-4BAD93FC-0AEE-4311-A080-BC341F06A559 Q50624594-7C0BE4A1-C60D-44F4-98B7-728DFDE460A2

P2860

The future of biologic agents in the treatment of Sjögren's syndrome

http://www.wikidata.org/entity/Q24681044

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The future of biologic agents in the treatment of Sjögren's syndrome

@ast

The future of biologic agents in the treatment of Sjögren's syndrome

@en

The future of biologic agents in the treatment of Sjögren's syndrome

@nl

type

label

The future of biologic agents in the treatment of Sjögren's syndrome

@ast

The future of biologic agents in the treatment of Sjögren's syndrome

@en

The future of biologic agents in the treatment of Sjögren's syndrome

@nl

prefLabel

The future of biologic agents in the treatment of Sjögren's syndrome

@ast

The future of biologic agents in the treatment of Sjögren's syndrome

@en

The future of biologic agents in the treatment of Sjögren's syndrome

@nl

P1433

Q24681044-E3854A90-0CB0-486F-92C5-8933B414A2B8

P1476

Q24681044-8CA83AE2-597D-4D6D-8A58-C81AF5EED437

P2093

Q24681044-3B5666F5-6496-4E1B-A9C0-A550109A8670

Q24681044-44500926-0C3D-494D-9D62-8C7EE2365BAA

Q24681044-9FBE7691-31FD-4FC6-B6C5-DE66118D3C41

Q24681044-DBE16339-EC9B-47D5-A87E-7EBDA3A928DC

P2860

Q24681044-166C1ACA-E434-4854-B6BE-FF5EBEA65A90

Q24681044-3FA7183F-14AF-4DEE-A880-6C8A6F933A52

Q24681044-42967F08-7F21-4AB8-87E4-1D6AED2346D7

Q24681044-4C4CE960-9534-4975-BB54-46204FD3ED90

Q24681044-57D28AC8-9268-440B-AB60-926A25C834ED

Q24681044-709DCAC2-041C-49A6-A0CB-D79D77250AC7

Q24681044-7D09BEDE-A3AE-4C2B-9E4A-6180849A4E8E

Q24681044-83C0D578-881B-4B31-A1B5-C320C004D8EC

Q24681044-8C3AAF29-01C9-4C1D-BD7C-8BA4AB291BAB

Q24681044-9A29D885-7BB2-4D89-849D-F704F944CA8B

P2888

Q24681044-44693EC7-C117-444C-A4BE-0809FAB544FB

P304

Q24681044-30A9F2D6-3449-4FEC-902E-4B2A7E0CD125

P31

Q24681044-B72FF5BB-0A68-4240-9F99-D2D64FB28E23

Q24681044-D4C3962D-098F-492C-9312-44082A15BB5B

P356

Q24681044-3AFD5A72-2942-4AAA-B972-F1BEE78C5A21

P407

Q24681044-1F194E90-BAA5-4652-A48B-0FB1805CB3E1

P433

Q24681044-9B3753D0-FB67-44A6-8F06-3CE2C3502F8C

P478

Q24681044-C3EB6716-71FF-45CC-A415-902BC5FC951C

P50

Q24681044-F1468239-BC03-4CD9-9846-168EB8576963

P577

Q24681044-5CAF7190-400D-408C-A100-834A6BFF0B68

Q24681044-9651E53B-1B94-4DC6-94B8-C9BA4C995FA7

P5875

Q24681044-5270B24E-C340-4151-B4D4-58BBCC438DFB

P6179

Q24681044-2EEF57DE-C88C-4253-87AE-D05A840927A3

P698

Q24681044-3C550E01-1109-40D1-8B68-183567515AE1

P921

Q24681044-F6A07973-4FD3-4F0F-8EAD-3E52CD06340E

P932

Q24681044-090C0A0C-71A2-448A-BE51-E0C759428406

P356

S12016-007-8005-6

P1433

Clinical Reviews in Allergy & Immunology

P1476

The future of biologic agents in the treatment of Sjögren's syndrome

@en

P2093

Arjan Vissink

http://www.w3.org/2001/XMLSchema#string

Hendrika Bootsma

http://www.w3.org/2001/XMLSchema#string

Jiska M Meijer

http://www.w3.org/2001/XMLSchema#string

Justin Pijpe

http://www.w3.org/2001/XMLSchema#string

P2860

The current status of targeting BAFF/BLyS for autoimmune diseases

Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.

B-cell targeting in rheumatoid arthritis and other autoimmune diseases.

Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study

Biological therapies of autoimmune diseases.

Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy.

The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjögren's syndrome.

P2888

s12016-007-8005-6

P304

292-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-007-8005-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Cees G M Kallenberg

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5853414

http://www.w3.org/2001/XMLSchema#string

P6179

1012827564

http://www.w3.org/2001/XMLSchema#string

P698

17992596

http://www.w3.org/2001/XMLSchema#string

P921

Sjögren's syndrome

P932

2071970

http://www.w3.org/2001/XMLSchema#string